Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Children With Japanese Encephalitis
NCT01856205Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- May 2009
- Primary completion
- Aug 2009
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Japanese encephalitis (JE) comparing IVIG with Placebo (2 arms). Primary endpoint: Evidence of side effects of study drug at 192 hours. Started May 2009; status: completed.
02
Drugs
IgPro10
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01856205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856205.